Exagen inc. to participate in the 2022 btig medtech, digital health, life science & diagnostic tools conference

San diego, feb. 02, 2022 (globe newswire) -- exagen inc. (nasdaq: xgn), a leading provider of autoimmune testing solutions, today announced its participation in the btig medtech, digital health, life science & diagnostic tools conference, which takes place february 15-17, 2022. ron rocca, exagen's president and chief executive officer, and kamal adawi, exagen's chief financial officer, will participate in a virtual fireside chat on wednesday, february 16 at 2:00 pm et, which is accessible to conference attendees. management will also be participating in one-on-one meetings with investors during the event; meetings can be requested through btig.
XGN Ratings Summary
XGN Quant Ranking